NSCLC cell line tumor progression is associated with an upregulation of miR-1204, which may be attributed to its direct binding to the 3’-UTR of PITX1, resulting in downregulated PITX1 expression and enhanced proliferation of NSCLC cells. This evidence concerns the gene PITX1 and neoplasm.